Stockholm - Delayed Quote SEK

Quia Pharma AB (publ) (QUIA.ST)

0.0089
-0.0008
(-8.25%)
At close: May 9 at 5:29:58 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
-460
-460
-4,374
-3,334
-311
Gross Profit
460
460
4,374
3,334
311
Operating Expense
29,125
29,125
19,886
19,128
17,880
Operating Income
-28,665
-28,665
-15,512
-15,794
-17,569
Net Non Operating Interest Income Expense
-264
-264
-1,011
-4,295
-2,431
Pretax Income
-28,929
-28,929
-16,523
-20,089
-20,000
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-28,929
-28,929
-16,523
-20,089
-20,000
Diluted NI Available to Com Stockholders
-28,929
-28,929
-16,523
-20,089
-20,000
Basic EPS
-0.02
--
-0.02
-0.08
-11.86
Diluted EPS
-0.02
--
-0.02
-0.08
-11.86
Basic Average Shares
1,264,634.6690
--
656,826.2900
236,217.0870
1,690.7820
Diluted Average Shares
1,264,634.6690
--
656,826.2900
236,217.0870
1,690.7820
Total Operating Income as Reported
-28,665
-28,665
-15,512
-15,794
-17,569
Total Expenses
28,665
28,665
15,512
15,794
17,569
Net Income from Continuing & Discontinued Operation
-28,929
-28,929
-16,523
-20,089
-20,000
Normalized Income
-28,929
-28,929
-16,523
-20,089
-20,000
Interest Income
1
1
2
0
--
Interest Expense
265
265
1,013
4,295
2,431
Net Interest Income
-264
-264
-1,011
-4,295
-2,431
EBIT
-28,664
-28,664
-15,510
-15,794
-17,569
EBITDA
-9,712
-9,712
-11,651
-12,426
-15,368
Reconciled Cost of Revenue
-460
-460
-4,374
-3,334
-311
Reconciled Depreciation
18,952
18,952
3,859
3,368
2,201
Net Income from Continuing Operation Net Minority Interest
-28,929
-28,929
-16,523
-20,089
-20,000
Normalized EBITDA
-9,712
-9,712
-11,651
-12,426
-15,368
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/21/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APTA.ST Aptahem AB (publ)
0.8020
+0.25%
 
NANECH.ST NanoEcho AB
0.1158
+7.22%
 
DBP-B.ST Double Bond Pharmaceutical Int.
0.3750
-8.31%
 
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
 
2CUREX.ST 2cureX AB (publ)
1.7700
-23.71%
 
ISOFOL.ST Isofol Medical AB (publ)
1.8580
+2.14%
 
IMMU.ST Mendus AB (publ)
5.78
-3.51%
 
SCOL.ST Scandion Oncology A/S
0.0188
+3.30%
 
KAN.ST Kancera AB (publ)
1.0880
+0.37%
 
XSPRAY.ST Xspray Pharma AB (publ)
32.10
-8.29%